• GluN2A/B, Connexins, and TMJ Inflammatory Allodynia

  2026-08-22

  The reference study identifies a subunit-specific pathway linking GluN2A and GluN2B N-methyl-D-aspartate receptors with connexin- and pannexin-dependent communication in the trigeminal ganglion during temporomandibular joint inflammation. By combining conditional knockout mice, behavioral testing, satellite glial cell experiments, and pathway analysis, it clarifies how peripheral sensitization may sustain orofacial inflammatory allodynia.

• SPRTN’s Dual Ubiquitin Binding in DPC Repair

  2026-08-22

  The reference preprint identifies a ubiquitin-binding region within the N-terminal catalytic region of SPRTN and shows how ubiquitin chains enhance selective DNA-protein crosslink proteolysis. Its central contribution is a mechanistic model in which ubiquitination acts as a rapid substrate-recognition signal, helping explain how SPRTN distinguishes damaged chromatin proteins from unmodified substrates.

• Caffeine Workflows for Cancer and Metabolism

  2026-08-21

  Build reproducible Caffeine experiments for sarcoma cell inhibition, VPA combination testing, and energy-balance studies in diet-induced obesity mouse models. This guide also explains how the ALDH2 ischemia literature can inform assay controls without overstating Caffeine’s cardiovascular evidence.

• FXR–KLF11 Signaling in Contrast-Induced AKI

  2026-08-20

  A 2026 study identifies an FXR–KLF11 transcriptional axis that protects against contrast-induced acute kidney injury by suppressing JAK2/STAT3 signaling. Using mouse, HK-2 cell, transcriptomic, reporter, chromatin, and genetic approaches, the work connects CDCA-driven FXR activation with reduced tubular inflammation, apoptosis, and tissue injury.

• Artesunate: In Vitro Cancer Assay Workflows

  2026-08-20

  Artesunate is an artemisinin derivative for dissecting growth inhibition, ferroptosis, and pathway-linked responses in cancer cell models. This workflow guide translates those properties into reproducible small cell lung carcinoma research and esophageal squamous cell carcinoma assay strategies.

• Electrical Stimulation Enhances Nanoparticle Endocytosis

  2026-08-19

  The reference study shows that alternating-current electrical stimulation increases magnetic nanoparticle uptake by cancer cells without requiring particle-surface functionalization. In osteosarcoma cells, the effect was associated with macropinocytosis, reduced F-actin content, and elevated intracellular Ca2+, with corresponding improvements in magnetic hyperthermia and MRI performance.

• Biotin in Kinesin Transport Assay Design

  2026-08-19

  Biotin and Vitamin B7 are more than metabolic cofactors: they can provide a precise capture and detection interface for reconstituted motor-protein assays. This article connects biotin chemistry with the BicD–MAP7 model of kinesin-1 activation to guide better experimental design.

• Midecamycin: Mechanism, MICs, and Research Use

  2026-08-18

  Midecamycin is a 16-membered, acetoxy-substituted macrolide antibiotic and bacterial protein synthesis inhibitor with strongest reported activity against Gram-positive organisms. Its A2058-directed mechanism, glycosylation-sensitive 2''-OH site, MIC benchmarks, solubility limits, and storage requirements define its use as an antibiotic research compound.

• NET-DNA–CCDC25 Axis in Intestinal Repair

  2026-08-18

  This FASEB Journal study identifies a mechanistic link between neutrophil extracellular trap DNA, CCDC25 signaling in group 3 innate lymphoid cells, and impaired IL-22-dependent intestinal epithelial repair. Its combination of mouse models, transcriptomics, cell perturbation, and epithelial barrier assays suggests that NET-DNA is not only a marker of ulcerative colitis activity but also an active suppressor of mucosal healing.

• S-Adenosylhomocysteine in Neural Differentiation Assays

  2026-08-17

  S-Adenosylhomocysteine enables controlled testing of how methylation potential may intersect with radiation-induced neural differentiation. This workflow combines SAH dosing, SAM/SAH ratio modulation, pathway-resolved readouts, and rescue controls without overstating findings that have not yet been demonstrated in neural cells.

• DED Assembly Mechanisms in Apoptosis

  2026-08-17

  The reference study defines atomic features of human FADD–procaspase-8–cFLIP death-effector-domain complexes using X-ray crystallography and cryo-EM. Its structures explain how the same signaling architecture can support limited caspase-8 activity, apoptosis control, and suppression of RIPK1-dependent necroptosis.

• From Fyn–Stat3 Biology to Precision Gene Editing

  2026-08-16

  The Fyn–Stat3 axis provides a compelling example of how mechanistic neurodegeneration research can evolve from pathway observation to causal testing. This article outlines how EZ Cap™ Cas9 mRNA (5-moUTP) can support controlled CRISPR-Cas9 genome editing studies in zebrafish and other translational models while keeping experimental interpretation, delivery, and limitations in view.

• Mitochondrial Permeability Transition Pore Assay Kit

  2026-08-15

  Turn mitochondrial pore opening into a measurable fluorescence endpoint with a workflow suited to infection, stress, and cell-death models. This guide shows how to combine Calcein retention, cobalt quenching, ionomycin controls, and orthogonal mitochondrial readouts for more defensible mechanism studies.

• Spermine Workflows for Ion Channel Research

  2026-08-14

  Use Spermine to build controlled inward-rectifier assays, distinguish polyamine-dependent conductance from magnesium effects, and connect electrophysiology with membrane-organization phenotypes. A practical two-track workflow also shows how the CLCC1 herpesvirus nuclear-egress study can inform assay design without implying a direct Spermine–CLCC1 mechanism.

• Foretinib: From Kinase Potency to Translation

  2026-08-14

  Foretinib (GSK1363089) offers translational researchers a way to interrogate convergent Met, VEGFR, and related receptor tyrosine kinase signaling. This article moves beyond potency tables to show how assay design, response decomposition, and metastasis-oriented models can turn a multikinase perturbation into more interpretable cancer biology.

8479 records 1/566 page Next 12345 下5页 Last page